Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVETIRACETAM Cause Diffuse large b-cell lymphoma? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Diffuse large b-cell lymphoma have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.0% of all adverse event reports for LEVETIRACETAM.

7
Reports of Diffuse large b-cell lymphoma with LEVETIRACETAM
0.0%
of all LEVETIRACETAM reports
5
Deaths
5
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From LEVETIRACETAM?

Of the 7 reports, 5 (71.4%) resulted in death, 5 (71.4%) required hospitalization.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does LEVETIRACETAM Cause?

Seizure (9,961) Drug ineffective (8,666) Off label use (5,789) Maternal exposure during pregnancy (3,197) Foetal exposure during pregnancy (2,604) Epilepsy (2,546) Generalised tonic-clonic seizure (2,276) Somnolence (2,070) Fatigue (1,972) Status epilepticus (1,883)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which LEVETIRACETAM Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

LEVETIRACETAM vs LEVOBUNOLOL LEVETIRACETAM vs LEVOBUPIVACAINE LEVETIRACETAM vs LEVOCARNITINE LEVETIRACETAM vs LEVOCETIRIZINE LEVETIRACETAM vs LEVODOPA

Related Pages

LEVETIRACETAM Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma LEVETIRACETAM Demographics